Raploc

Medicinal product

(Invented) name

Raploc

Active substance (s)

Landiololio hidrochloridas

Strength

20 mg/2 ml

Pharmaceutical form

koncentratas injekciniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C07AB14, Landiolol

Marketing authorisation holder

Amomed Pharma GmbH , Austrija

Date of authorisation

2017-02-13

Date of renewal

2021-10-01

Documents

4047 Raploc konc inj RPP 2021 11 24.docx

4047 Pakuotės lapelis konc 2021 11 24.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

NL/H/3368/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kiekvienoje ampulėje (2 ml) yra	2 ml
Landiololio hidrochloridas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60987	75296	1075296	ampulė	2 ml N5		Receptinis	LT/1/17/4047/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-10-01	Perregistruotas
2017-02-13	Registruotas